Fingerprint
Dive into the research topics of 'Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
Robert F. Kushner, Salvatore Calanna, Melanie Davies, Dror Dicker, W. Timothy Garvey, Bryan Goldman, Ildiko Lingvay, Mette Thomsen, Thomas A. Wadden, Sean Wharton, John P.H. Wilding, Domenica Rubino
Research output: Contribution to journal › Article › peer-review
146
Scopus
citations